Connor Ahearn
Areas of Focus
Overview
Connor Ahearn is a senior counsel in Crowell & Moring’s Washington, D.C. office and is a member of the firm’s Antitrust and Competition Group. Connor’s practice involves counseling clients on a wide range of antitrust issues, including compliance with the Hart-Scott-Rodino Act, identifying and coordinating foreign merger control filings, and evaluating and advising on competitive issues associate with mergers, acquisitions, and competitor collaborations.
Career & Education
- College of William & Mary, B.A., cum laude, 2010
- University of Virginia, J.D., 2017
- District of Columbia
- Virginia
Connor's Insights
Client Alert | 3 min read | 02.24.26
DOJ v. OhioHealth Confirms Antitrust Enforcers’ Continued Focus on Health Care Markets
On February 20, 2026, the Department of Justice’s Antitrust Division (DOJ) and Ohio Attorney General (Ohio AG) sued OhioHealth Corporation (OhioHealth), alleging that OhioHealth had unlawfully restrained trade in the market for general acute care inpatient hospital services in the Columbus metropolitan statistical area and the narrower Central Columbus area, respectively. The DOJ and Ohio AG allege violations of Section 1 of the Sherman Act, as well as the Valentine Act (Ohio’s antitrust statute), claiming that OhioHealth leveraged its market power to impose contractual restrictions that blocked payors from working with competing health systems to design “budget-conscious” lower-cost health plans.
Client Alert | 3 min read | 02.13.26
Client Alert | 1 min read | 01.20.26
Client Alert | 3 min read | 01.15.25
Speedbump or Roadblock?: Complaint Challenges New Hart-Scott-Rodino Rules
Representative Matters
- Representing DIRECTV as antitrust counsel in its proposed acquisition of the DISH video distribution business from EchoStar, including leading the merger review process before DOJ and providing strategic counsel and advice in connection with the transaction.
- Representing United Technologies in connection with its $135 billion merger with The Raytheon Company, which The Deal named its 2020 "Deal of the Year," its $30 billion acquisition of Rockwell Collins, and its $16.5 billion acquisition of Goodrich.
- Advising DuPont De Nemours on international merger control notification obligations.
- Representing Gwinnett Health System in its merger with Northside Hospital.
- Representing United Technologies in its $30 billion acquisition of Rockwell Collins.
Connor's Insights
Client Alert | 3 min read | 02.24.26
DOJ v. OhioHealth Confirms Antitrust Enforcers’ Continued Focus on Health Care Markets
On February 20, 2026, the Department of Justice’s Antitrust Division (DOJ) and Ohio Attorney General (Ohio AG) sued OhioHealth Corporation (OhioHealth), alleging that OhioHealth had unlawfully restrained trade in the market for general acute care inpatient hospital services in the Columbus metropolitan statistical area and the narrower Central Columbus area, respectively. The DOJ and Ohio AG allege violations of Section 1 of the Sherman Act, as well as the Valentine Act (Ohio’s antitrust statute), claiming that OhioHealth leveraged its market power to impose contractual restrictions that blocked payors from working with competing health systems to design “budget-conscious” lower-cost health plans.
Client Alert | 3 min read | 02.13.26
Client Alert | 1 min read | 01.20.26
Client Alert | 3 min read | 01.15.25
Speedbump or Roadblock?: Complaint Challenges New Hart-Scott-Rodino Rules
Insights
Connor's Insights
Client Alert | 3 min read | 02.24.26
DOJ v. OhioHealth Confirms Antitrust Enforcers’ Continued Focus on Health Care Markets
On February 20, 2026, the Department of Justice’s Antitrust Division (DOJ) and Ohio Attorney General (Ohio AG) sued OhioHealth Corporation (OhioHealth), alleging that OhioHealth had unlawfully restrained trade in the market for general acute care inpatient hospital services in the Columbus metropolitan statistical area and the narrower Central Columbus area, respectively. The DOJ and Ohio AG allege violations of Section 1 of the Sherman Act, as well as the Valentine Act (Ohio’s antitrust statute), claiming that OhioHealth leveraged its market power to impose contractual restrictions that blocked payors from working with competing health systems to design “budget-conscious” lower-cost health plans.
Client Alert | 3 min read | 02.13.26
Client Alert | 1 min read | 01.20.26
Client Alert | 3 min read | 01.15.25
Speedbump or Roadblock?: Complaint Challenges New Hart-Scott-Rodino Rules
